Evidence map›Paper›PMID 28498270›Full record

Observational studyOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology2017

Age-Related Increase in Blood Levels of Otolin-1 in Humans.

Ryan Tabtabai, Laura Haynes, George A Kuchel, Kourosh Parham

Abstract readObservational Study
In one paragraph

Observational study in Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Blood Biomarkers for the Diagnosis of Peripheral Causes of Vestibular Syndrome: A Systematic Review and Meta-Analysis.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2025
    Pooled it
  2. Pooled it
  3. Serum otolin-1 levels in vestibular migraine and Ménière's disease: a comparative clinical study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Normal Serum Levels of Otolin-1 in Patients with Meniere Disease in Remission.International archives of otorhinolaryngology · 2023
    Article
  10. A potential serological biomarker for inner ear pathologies: OTOLIN-1.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2022
    Article
  11. Article
  12. Article
  13. Otolin-1, as a Potential Marker for Inner Ear Trauma after Mastoidectomy.The journal of international advanced otology · 2019
    Article
  14. Article
  15. A Relationship Between Blood Levels of Otolin-1 and Vitamin D.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ryan Tabtabai*Division of Otolaryngology-Head & Neck Surgery, Department of Surgery †Center on Aging ‡Department of Immunology, University of Connecticut School of Medicine, Farmington, Connecticut.
Laura Haynes
George A Kuchel
Kourosh Parham
University of Connecticut · US

Funding

MOLECULAR BIOLOGY COREP01AG021600 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA · 2003 to 2016
$24.4M
High-resolution single cell profiling of vaccine responsiveness in the elderlyR01AI142086 · NIAID · JACKSON LABORATORY · PI UCAR, DUYGU · 2019 to 2023
$2.9M
Immune Response to High-Dose vs. Standard Dose Influenza VaccineR01AG048023 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KUCHEL, GEORGE A, MCELHANEY, JANET E. · 2014 to 2018
$2.1M
NIAID NIH HHS R01 AI142086NIA NIH HHS P01 AG021600NIA NIH HHS R01 AG048023
6 · The paper itself

Abstract

objectiveTo test the hypothesis that age-related demineralization of otoconia will result in an age-related increase in blood levels of otoconia matrix protein, otolin-1. STUDY

designCross-sectional observational clinical trial.

settingClinical research center. PATIENTS: Seventy nine men and women ranging in age from 22 to 95 years old.

interventionsDiagnostic.

main outcome measuresBlood levels of otolin-1 in relation to age.

resultsLevels of otolin-1 of subjects divided into four age groups (1: 20-30 [n = 20], 2: 50-65 [n = 20], 3: 66-80 [n = 20], 4: 81-95 [n = 19] years old) demonstrated an increasing trend with age. The difference between otolin levels of groups 2 and 3, as well as, (p = 0.04) and 2 and 4 (p = 0.031) were statistically significant, but there was no significant difference between the two oldest groups.

conclusionsOtolin-1 blood levels are significantly higher in patients older than 65 years of age. This is consistent with previous scanning electron microscopy findings of age-related otoconia degeneration and increased prevalence of benign paroxysmal positional vertigo (BPPV) with age. Normative data provided here can serve as important reference values against which levels from BPPV patients can be compared with further evaluate otolin-1 as a circulatory biomarker for otoconia degeneration.

Indexed as

AdultAgedAged, 80 and overAgingBenign Paroxysmal Positional VertigoBiomarkersCross-Sectional StudiesExtracellular Matrix ProteinsFemaleHumansMaleMiddle AgedYoung AdultBiomarkersExtracellular Matrix Proteinsotolin-1

Identifiers

PMID28498270
PMCPMC5464974
OpenAlexW2612446843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.